I have to admit, I didn't really see Chimeric as an IMU 2.0 initially, more as a smaller sibling. But as their pipeline has developed, I think you're spot on. They clearly have the potential here to rival Imugene as a sizeable Aussie bio. And they have moved incredibly quickly. With a ~AUD$50M market cap currently, it's a steal and I don't imagine it will be too long before the market starts to value it more accurately - and dare we say, like Imugene.
And yep, I reckon in time we'll see an IMU/CHM collab with OnCARltyics and CAR Ts.
Blimey, hard not to get excited by that. I'll be quite happy to average up with this one I think.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)